D‐dimer assays are commonly used in clinical practice to exclude a diagnosis of deep vein
thrombosis or pulmonary embolism. More recently, they have been also been used to guide …

Background: Clinical probability assessment is combined with d-dimer testing to exclude
pulmonary embolism (PE). Purpose: To compare the test characteristics of gestalt (a …

Background: Pretest probability assessment is necessary to identify patients in whom
pulmonary embolism (PE) can be safely ruled out by a negative D-dimer without further …

Background: Several clinical decision rules (CDRs) are available to exclude acute
pulmonary embolism (PE), but they have not been directly compared. Objective: To directly …

Summary Background Multislice CT (MSCT) combined with D-dimer measurement can
safely exclude pulmonary embolism in patients with a low or intermediate clinical probability …

Risk prediction models can be used to estimate the probability of either having (diagnostic
model) or developing a particular disease or outcome (prognostic model). In clinical …

Background The revised Geneva score is a fully standardized clinical decision rule (CDR) in
the diagnostic workup of patients with suspected pulmonary embolism (PE). The variables of …

Acute deep vein thrombosis (DVT) and pulmonary embolism (PE) represent two expressions
of a similar clinical pathological process, often referred to as venous throm-boembolism …

Clinical outcome studies have shown that it is safe to withhold anticoagulant therapy in
patients with suspected pulmonary embolism (PE) who have a negative D-dimer result and …

Objective To validate the use of the Wells clinical decision rule combined with a point of care
D-dimer test to safely exclude pulmonary embolism in primary care. Design Prospective …